Sydnexis low-dose atropine for childhood myopia heads to Oct 30 advisory committee
- Sponsor
- Sydnexis
- Drug
- atropine sulfate
- Indication
- Slowing myopia progression in children 3 years and older
FDA advisers will meet October 30 to review Sydnexis's NDA for atropine 0.01% eye drops to slow myopia progression in children 3 and older.
Read original at federalregister.gov ↗From the source
Request Access
Due to aggressive automated scraping of FederalRegister.gov and eCFR.gov, programmatic access to these sites is limited to access to our extensive developer APIs. Please visit
FederalRegister.gov API
documentation or
eCFR.gov API
documentation to learn more about how to access the API.
Your request has been flagged as potentially automated. If you are human user receiving this message, please complete the CAPTCHA (bot test) below and click "Request Access". You may occassionally be asked to complete the CAPTCHA again, this is normal and part of our security measures.
unblock#handleSubmit">
Request Access
An official website of the United States government.
If you experiencing issues with the CAPTCHA or want to request a wider IP range, you can use the "Site Help" button found in the lower, right of this page to make a request.
×
IP Access Help
This contact form is only for IP Access help. Please do not provide confidential information or personal data.
* Your Name
* How can we help you?
Upload Attachment
* I am requesting technical help.
site-feedback#openModal" aria-label="Open site help form">
Site Help
Reproduced from Federal Register — FDA Advisory Committees · view original · public domain or open-licensed government work
Drug Watch — recent news on atropine sulfate
- Association of Age and Spherical Equivalent With Differences in Cycloplegic Refractive Effects Between Cyclopentolate and Atropine - Cureus
- Low-dose atropine drops, 0.01%, ineffective in stopping myopia progression in children - Ophthalmology Times
- Low-Dose Atropine for Childhood Myopia: Worth Using? - Medscape
- Atropine vs Cyclopentolate for Cycloplegic Refraction: Impact on Premyopia Diagnosis in Preschool Children - Vera Health
- Atropine vs Cyclopentolate for Cycloplegic Refraction: Impact on Premyopia Diagnosis in Preschool Children - Vera Health